New Zealand markets open in 6 hours 17 minutes

Immix Biopharma, Inc. (IMMX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.9800-0.1500 (-7.04%)
At close: 04:00PM EDT
1.8500 -0.13 (-6.57%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
10,665
8,735
4,196
126.527
248.149
-
Selling general and administrative
8,546
7,406
4,023
1,225
205.703
-
Total operating expenses
19,210
16,141
8,219
1,352
453.852
-
Operating income or loss
-19,210
-16,141
-8,219
-1,352
-453.852
-
Interest expense
-
0
0.497
179.853
101.976
-
Total other income/expenses net
-
-
-
-22,846
-574.488
0.224
Income before tax
-18,398
-15,569
-8,219
-24,378
-1,130
-
Income tax expense
30.084
26.415
10.268
6.013
17.547
-
Income from continuing operations
-18,429
-15,596
-8,230
-24,384
-1,148
-
Net income
-18,205
-15,426
-8,230
-24,384
-1,148
-
Net income available to common shareholders
-18,205
-15,426
-8,230
-24,384
-1,148
-
Basic EPS
-0.92
-
-0.59
-6.64
-0.13
-0.12
Diluted EPS
-0.92
-
-0.59
-6.64
-0.13
-0.12
Basic average shares
15,374
-
13,887
3,673
8,775
8,443
Diluted average shares
15,374
-
13,887
3,673
8,775
8,443